News
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
2d
Capital Brief on MSNCochlear secures FDA approval for triple product launchHearing device maker Cochlear has received regulatory approval from the US Food and Drug Administration (FDA) for its new ...
The Cochlear Nucleus Nexa System. Picture: Supplied In February, Cochlear reported an underlying net profit of $206m, a 7 per cent rise.
9don MSN
A recent study of outcomes in infants and young deaf children with cochlear implants (implanted electronic hearing device), ...
Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...
The Model S now starts at $86,630, with the Model S Plaid cresting six figures and starting at $101,630. The standard-range Model X now starts at $91,630, and the Model X Plaid at $106,630.
COH Substantial Shareholders Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cochlear Limited (COH). However, you won't necessarily see their ...
Starbucks (SBUX.O) CEO Brian Niccol told Reuters on Tuesday that he would accelerate the rollout of the coffeehouse chain's new staffing and service model, aiming for all North American stores by ...
Mistral emphasizes the model’s “multilingual dexterity,” highlighting high-fidelity performance in languages including French, Spanish, German, Italian, Arabic, Russian and Simplified Chinese.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results